BioPharm International, August 2011 Issue (PDF)
Top 1000 Biomanufacturing Facilities
Efficient Multiproduct Process Development Case Study
Achieving multiproduct development within shortened timelines.
Offshoring Biomanufacturing
China rises to the top as a destination for international outsourcing.
Particulate Quality of Single-Use Filling Systems
The author looks at strategies to minimize particle levels in the finished product when using single-use technologies downstream of final capabilities.
Developing an International Dialogue on Biologics Standards
US Pharmacopeia promotes horizontal standards and a product-class approach for quality attributes.
FDA Maps Strategy to Counter Supply-Chain Threats
Rising imports, overseas production spur collaboration and realignment of enforcement activities.
Challenging the Cleanroom Paradigm for Biopharmaceutical Manufacturing of Bulk Drug Substances
The authors re-examine environmental controls in the context of technical advances in manufacturing.
Biopharmaceutical High Performance
Industry may be its own obstacle to success in achieving the desired high-performance state.
Biosimilars or Bust
Are biosimilars the next big thing or just the next big bubble?
Top 1000 Global Biomanufacturing Facilities
Insights from real-time ranking of global biomanufacturing capabilities.
